2021•Eye South East AsiaOpen access

Effect of switching treatment to ranibizumab or aflibercept for diabetic macular edema in patients refractory to bevacizumab

Navapol Kanchanaranya, Paiboon Bowornwattanadilok, Onnicha Srivanich

Open full text 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Ranibizumab, Aflibercept, Bevacizumab, Medicine, Diabetic macular edema, Refractory (planetary science), Ophthalmology, Diabetic retinopathy

Back to paper search Browse research topics Original source

Effect of switching treatment to ranibizumab or aflibercept for diabetic macular edema in patients refractory to bevacizumab — Research Paper | ScholarLens